参考文献/References:
[1] SHRIBMAN S,POUJOIS A,BANDMANN O,et al.Wilson's disease:Update on pathogenesis,biomarkers and treatments[J].J Neurol Neurosurg Psychiatry,2021,92(10):1053-1061.
[2] GEROSA C,FANNI D,CONGIU T,et al.Liver pathology in Wilson's disease:From copper overload to cirrhosis[J].Inorg Biochem,2019,193:106-111.
[3] 李波,董丽,王晓栋,等.基于肝玄府理论探讨风药在肝病中的应用[J].中国中医急症,2014,23(1):65-66.
[4] 陈海洋,张玮.基于“五脏相关”的补虚化瘀解毒法辨治慢性乙型肝炎[J].中西医结合肝病杂志,2024,34(2):163-166.
[5] 范丽妃,林敏,郭玉琴,等.基于络病理论探讨脏器纤维化中医辨治策略的共性研究与展望[J].中华中医药杂志,2024,39(2):584-587.
[6] 李兴鹏,马晖.冯全生教授基于“主客交”理论治疗慢性肝病经验浅析[J].四川中医,2022,40(8):9-11.
[7] 钱南南,杨文明,魏涛华,等.肝豆状核变性伏毒阻络病因病机探要[J].中国实验方剂学杂志,2022,28(12):133-140.
[8] 阮雅楠,杨文明.肝豆状核变性的伏邪致病动态分层辨析[J].中华中医药杂志,2022,37(2):999-1002.
[9] 郝文杰,杨文明,魏涛华,等.基于“肝络微癥积”学说探讨中医药抗肝豆状核变性肝纤维化治疗策略[J].北京中医药大学学报,2022,45(3):307-312.
[10] 朱璐璐,王汉裕,吕东勇,等.基于中医阴阳学说探讨巨噬细胞极化在肝纤维化中的作用[J].中医杂志,2019,60(12):1025-1029.
[11] ZHANG J,FU Y,YANG B,et al.Total glucosides of paeony inhibits liver fibrosis and inflammatory response associated with cirrhosis via the FLI1/NLRP3 axis[J].Am J Transl Res,2022,14(6):4321-4336.
[12] SHEN M,MEN R,FAN X,et al.Total glucosides of paeony decreases apoptosis of hepatocytes and inhibits maturation of dendritic cells in autoimmune hepatitis[J].Biomed Pharmacother,2020,124:109911.
[13] LIU R J,HE Y J,LIU H,et al.Protective effect of lycium barbarum polysaccharide on di-(2-ethylhexyl)phthalate-induced toxicity in rat liver[J].Environ Sci Pollut Res Int,2021,28(18):23501-23509.
[14] GAO L L,MA J M,FAN Y N,et al.Lycium barbarum polysaccharide combined with aerobic exercise ameliorated nonalcoholic fatty liver disease through restoring gut microbiota,intestinal barrier and inhibiting hepatic inflammation[J].Int J Biol Macromol,2021,183:1379-1392.
[15] 韩艳珍,单铁英,李伟,等.口服枸杞多糖对小鼠肝纤维化组织基质金属蛋白酶-2及基质金属蛋白酶-2抑制剂水平影响的实验研究[J].陕西医学杂志,2021,50(3):276-279.
[16] 陈志亮,黄霞,顾宁.名中医顾宁创制化湿降浊方辨治高尿酸血症经验[J].陕西中医,2023,44(11):1617-1619.
[17] GONG X,SHAN L,CAO S,et al.Notoginsenoside R1,an active compound from panax notoginseng,inhibits hepatic stellate cell activation and liver fibrosis via MAPK signaling pathway[J].Am J Chin Med,2022,50(2):511-523.
[18] 周兴宏,刘晓瑜,温子云,等.三七皂苷R1上调miR-146a水平和减轻ApoE-/-小鼠肝脏炎症损伤的研究[J].中药新药与临床药理,2016,27(3):317-321.
[19] 梁瀞云,唐燕,司马玲,等.柴胡疏肝散在肝脏疾病中的应用研究进展[J].陕西中医,2022,43(11):1651-1653.
[20] 周淑娟,陈岩岩,李琤,等.柴胡疏肝散调控Notch通路抑制慢性脂肪性肝炎大鼠肝纤维化的研究[J].上海中医药杂志,2022,56(10):57-64.
[21] LI X,GE J,LI Y,et al.Integrative lipidomic and transcriptomic study unravels the therapeutic effects of saikosaponins A and D on non-alcoholic fatty liver disease[J].Acta Pharm Sin B,2021,11(11):3527-3541.
[22] WU H,YU T,TIAN Y,et al.Enhanced liver-targeting via coadministration of 10-Hydroxycamptothecin polymeric micelles with vinegar baked Radix Bupleuri[J].Phytomedicine,2018,44:1-8.
[23] 杨翠荣.郁金药理及中医临床应用略述[J].光明中医,2014,29(8):1772-1773.
[24] ZHAO Y,KONG H,LI Y,et al.Inhibitory effects of Curcumae Radix carbonisata-based carbon dots against liver fibrosis induced by carbon tetrachloride in mice[J].Artif Cells Nanomed Biotechnol,2024,52(1):23-34.
[25] CHEN Z,LI W,QUAN L,et al.The effects of Curcumae Longae Radix,Curcuma phaeocaulis Radix and their processed products on Epo/EpoR Pathway and CD62p[J].Front Pharmacol,2018,9:736.
[26] 杨文明,方芳,汪美霞,等.肝豆扶木汤治疗Wilson病肝纤维化的临床研究[J].中医药临床杂志,2014,26(11):1111-1113.
[27] 杨悦.肝豆扶木汤治疗Wilson病肝纤维化临床疗效及对TX-J小鼠肝纤维化作用机制研究[D].合肥:安徽中医药大学,2022.
[28] 马守亮,韩冰,杨文明,等.肝豆扶木汤治疗Wilson病步态障碍痰瘀互结证的临床研究[J].中医药学报,2023,51(8):56-60.
[29] 魏涛华,杨文明,唐露露,等.基于网络药理学探讨肝豆扶木汤治疗肝豆状核变性肝纤维化的作用机制及实验验证[J].中国中西医结合杂志,2021,41(8):981-990.
[30] 郝文杰,杨文明,魏涛华,等.基于生物信息学和细胞实验探讨肝豆扶木汤调控铁死亡治疗肝豆状核变性的作用[J].中成药,2023,45(10):3461-3468.
[31] 钱南南,杨文明,魏涛华,等.肝豆扶木汤通过调控miR-29b-3p/ULK1表达对Wilson病肝纤维化小鼠自噬的影响[J].中国实验方剂学杂志,2024,30(2):17-25.
[32] 唐露露,张静,魏涛华,等.肝豆扶木汤对CuCl2诱导的HepG2细胞氧化损伤的保护作用和机制[J].中国实验方剂学杂志,2021,27(12):48-56.
[33] 唐露露,杨文明,谢文婷,等.肝豆扶木汤对Wilson病肝纤维化TX小鼠肝组织TβRⅠ、TβRⅡ和Smad4表达的影响[J].中华中医药杂志,2019,34(9):4043-4047.
相似文献/References:
[1]雷 玲,闵 珺,刘 锋,等.黄芪对肝纤维化大鼠肝损伤保护作用及机制研究*[J].陕西中医,2020,(9):1192.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.004]
LEI Ling,MIN Jun,LIU Feng,et al.Study on protective effects and mechanism of astragalus on hepatic injury of rats with hepatic fibrosis[J].,2020,(4):1192.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.004]
[2]蒋淑莲,谭善忠,文 剑.柴芍六君汤治疗慢性乙型肝炎肝纤维化疗效及对患者血清Treg/Th17的影响[J].陕西中医,2021,(9):1229.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.020]
JIANG Shulian,TAN Shanzhong,WEN Jian.Therapeutic effect of Chaishao Liujun decoction on hepatic fibrosis in chronic hepatitis B and effect on serum Treg/Th17[J].,2021,(4):1229.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.020]
[3]蔡 菁,葛亚强,许丽娟,等.蒿属香豆素对MCD饮食诱导的非酒精性脂肪性肝纤维化小鼠保护性作用的研究[J].陕西中医,2021,(11):1511.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.004]
CAI Jing,GE Yaqiang,XU Lijuan,et al.Protective effect of scoparone on MCD diet induced liver fibrosis in mice[J].,2021,(4):1511.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.004]
[4]吴必建,章一凡.猪苓汤加味联合多烯磷脂酰胆碱治疗早期肝硬化疗效研究[J].陕西中医,2021,(12):1706.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.013]
[5]苟 芳,张红军,王 洁,等.黄连解毒汤通过抑制TGF-β信号通路减轻2型糖尿病大鼠肝脂肪变性和纤维化研究[J].陕西中医,2022,(2):170.[doi:DOI:10.3969/j.issn.1000-7369.2022.02.007]
GOU Fang,ZHANG Hongjun,WANG Jie,et al.Huanglian Jiedu decoction alleviates hepatic steatosis and fibrosis in type 2 diabetic rats through activation of TGF - β signaling pathway[J].,2022,(4):170.[doi:DOI:10.3969/j.issn.1000-7369.2022.02.007]
[6]孙素红,周晓玲,李泽鹏,等.柴胡当归散加减联合穴位注射丹参注射液治疗乙肝肝纤维化临床观察[J].陕西中医,2024,(4):477.[doi:DOI:10.3969/j.issn.1000-7369.2024.04.009]
SUN Suhong,ZHOU Xiaoling,LI Zepeng,et al.Clinical observation on the treatment of liver fibrosis in hepatitis B with modified Chaihu Danggui powder combined with acupoint injection of Danshen injection[J].,2024,(4):477.[doi:DOI:10.3969/j.issn.1000-7369.2024.04.009]
[7]谢 旭,李国焕,贾文燕,等.参芪软肝汤配合抗病毒药物治疗肝硬化临床研究[J].陕西中医,2024,(6):771.[doi:DOI:10.3969/j.issn.1000-7369.2024.06.010]
XIE Xu,LI Guohuan,JIA Wenyan,et al.Shenqi Ruangan decoction combined with antiviral drugs in the treatment of liver cirrhosis[J].,2024,(4):771.[doi:DOI:10.3969/j.issn.1000-7369.2024.06.010]